Society of Interventional Radiology: Pioneering specialty reaches out

February 28, 2013

FAIRFAX, Va.--Online meeting registration is open for the Society of Interventional Radiology's Annual Scientific Meeting April 13 at the Ernest N. Morial Convention Center in New Orleans.

"The meeting's theme, 'IR Reaching Out,' illustrates the many ways the Annual Scientific Meeting provides valuable education to attendees across a broad range of diverse clinical interests and practice settings," said Gary P. Siskin, M.D., FSIR, the meeting's scientific program chair. "Annual Scientific Meeting attendees come from all areas: they are community or university-based physicians, physician assistants, nurse practitioners and radiology assistants, nurses, technologists, hospital administrators and industry partners. To complement our theme of inclusion, we've designed sessions that will meet the educational needs of all these various groups," said Siskin, who is professor and chair of the department of radiology at Albany Medical College, Albany, N.Y.

Approximately 5,300 attendees are expected to explore the latest interventional radiology research, evidence, techniques and technologies through a host of symposia, workshops and plenary and scientific sessions led by interventional radiology's key leaders. With "Prostate and Bladder Embolization," attendees will have the opportunity to review the current evidence on the use of embolization on the prostatic artery for the treatment of men's enlarged prostates. In "Renal Denervation: A Primer for Radiologists," experts will review the clinical evidence for this possible new way to treat hypertension, cardiac failure and other conditions. "Cosmetic IR: Going Beyond the Norm" explores the demand for minimally invasive cosmetic techniques. With insight from a diverse faculty that consists of academic and private practice interventional radiologists as well as physicians outside of the field, the "Future of IR" will examine the current state of interventional radiology and its short- and long-term outlook.

Siskin noted that this year's meeting includes contributions from several SIR service lines, including interventional oncology, peripheral arterial disease, interventional neuroradiology and venous disease. "This is a successful model of collaboration that promotes interventional radiology's role across disease states and provides attendees with insight into the specialty's clinical and multidisciplinary nature among varied practice settings," said Siskin.

"Annual Scientific Meeting programming will include more evidence-driven, innovative sessions on each aspect of interventional radiology," said Siskin. "So many things combine to make this year's program our most comprehensive to date. For example, there is a concentration on issues and challenges inherent to community-based practice in the new 'In the Trenches' series and the opportunity to spend time with interventional radiology experts during 'Meet the Professors.' In 'SIR Global,' we'll provide insight into the unique contributions that our colleagues in South America are making to the specialty," he noted.

"SIR 2013 will feature 400 abstracts, including 237 oral presentations that will highlight state-of-the-art technology and research evidence of best practices in the management and treatment of disease processes across the spectrum of interventional radiology. These sessions will also include the most current research on clinical trials, evidence and innovation," noted Daniel B. Brown, M.D., FSIR, the meeting's scientific program chair and chief of interventional radiology and interventional oncology at Thomas Jefferson University Hospital in Philadelphia.
-end-
The advanced registration deadline is March 8. For more information about the Society of Interventional Radiology and/or to register for the 38th Annual Scientific Meeting, visit www.SIRweb.org or www.SIRmeeting.org.

About the Society of Interventional Radiology

Interventional radiologists are physicians who specialize in minimally invasive, targeted treatments. They offer the most in-depth knowledge of the least invasive treatments available coupled with diagnostic and clinical experience across all specialties. They use X-ray, MRI and other imaging to advance a catheter in the body, such as in an artery, to treat at the source of the disease internally. As the inventors of angioplasty and the catheter-delivered stent, which were first used in the legs to treat peripheral arterial disease, interventional radiologists pioneered minimally invasive modern medicine. Today, interventional oncology is a growing specialty area of interventional radiology. Interventional radiologists can deliver treatments for cancer directly to the tumor without significant side effects or damage to nearby normal tissue.

Many conditions that once required surgery can be treated less invasively by interventional radiologists. Interventional radiology treatments offer less risk, less pain and less recovery time compared to open surgery. This year, SIR celebrates 40 years of innovation and advances in interventional radiology. Visit www.SIRweb.org.

The Society of Interventional Radiology is holding its 38th Annual Scientific Meeting April 14-18, 2013 at the Ernest N. Morial Convention Center in New Orleans. The theme of the meeting is 'IR Reaching Out,' adopted to illustrate the many ways the Annual Scientific Meeting provides valuable education to attendees with a broad range of diverse clinical interests and practice settings.

Representatives of the media are invited to join interventional radiology professionals as they share research, learn about the latest breakthroughs and trends in interventional radiology and discuss important issues in the field that have been making news. Press registration is complimentary to credentialed media. For press registration only, contact Ellen Acconcia, (703) 460-5582, eacconcia@SIRweb.org, or Maryann Verrillo, (703) 460-5572, mverrillo@SIRweb.org. Press representatives may also register online at www.SIRmeeting.org. SIR will hold two scientific press conferences: Sunday, Apr. 14 and Monday, Apr. 15, 9:00 - 10:30 a.m. (Central). Press conferences will feature an overview of the latest research and discoveries in the world of interventional radiology.

Society of Interventional Radiology

Related Clinical Trials Articles from Brightsurf:

Nearly 1 in 5 cancer patients less likely to enroll in clinical trials during pandemic
A significant portion of cancer patients may be less likely to enroll in a clinical trial due to the ongoing coronavirus pandemic.

COVID-19 clinical trials lack diversity
Despite disproportionately higher rates of COVID-19 infection, hospitalization and death among people of color, minority groups are significantly underrepresented in COVID-19 clinical trials.

Why we should trust registered clinical trials
In a time when we have to rely on clinical trials for COVID-19 drugs and vaccines, a new study brings good news about the credibility of registered clinical trials.

Inclusion of children in clinical trials of treatments for COVID-19
This Viewpoint discusses the exclusion of children from coronavirus disease 2019 (COVID-19) clinical trials and why that could harm treatment options for children.

Review evaluates how AI could boost the success of clinical trials
In a review publishing July 17, 2019 in the journal Trends in Pharmacological Sciences, researchers examined how artificial intelligence (AI) could affect drug development in the coming decade.

Kidney patients are neglected in clinical trials
The exclusion of patients with kidney diseases from clinical trials remains an unsolved problem that hinders optimal care of these patients.

Clinical trials beginning for possible preeclampsia treatment
For over 20 years, a team of researchers at Lund University has worked on developing a drug against preeclampsia -- a serious disorder which annually affects around 9 million pregnant women worldwide and is one of the main causes of death in both mothers and unborn babies.

Underenrollment in clinical trials: Patients not the problem
The authors of the study published this month in the Journal of Clinical Oncology investigated why many cancer clinical trials fail to enroll enough patients.

When designing clinical trials for huntington's disease, first ask the experts
Progress in understanding the genetic mutation responsible for Huntington's disease (HD) and at least some molecular underpinnings of the disease has resulted in a new era of clinical testing of potential treatments.

New ALS therapy in clinical trials
New research led by Washington University School of Medicine in St.

Read More: Clinical Trials News and Clinical Trials Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.